While most medical device giants employ thousands, Raywatt is betting on surgical precision—both in technology and team size—to disrupt the cardiovascular OCT market. With just 8 employees and $1.1M in revenue, this Korean startup is playing a game of quality over quantity.

"In medical devices, a team of 8 can't outspend giants—but they can out-innovate them on specific pain points."

The absence of global traffic data and their LinkedIn profile suggests Raywatt is in stealth or early commercialization phase. Their website's clean, professional design (implied by the tech stack) likely serves as a credibility hub for investors and medical partners rather than a direct-to-patient sales channel. In medical devices, this makes perfect sense: sales cycles are long, regulatory hurdles are high, and trust is built through clinical validation, not web traffic.

• Korean-first strategy: 100% of known traffic is from Korean searches, indicating strong domestic focus
• Hardware over software: Tech stack is website-focused, not product-focused—appropriate for a medical device company
• Lean operations: $137K revenue per employee suggests efficient early-stage operations
• LinkedIn presence: Minimal social footprint aligns with B2B medical device sales model